Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era
Article in ImmunoTargets and Therapy (July 2021)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in ImmunoTargets and Therapy (July 2021)
Article in Journal of Neurology Neurosurgery & Psychiatry (March 2021)
Article in Vaccines (December 2020)